- The trend backdrop is active with a 30-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
MRNA
MEX
Week ended 07 Aug 2026
Weekly Investor Report
Moderna, Inc. · Healthcare · Biotechnology
Latest close
1,010 MXN
4.7%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is 9.7% above the Trend Line and sits at 57.5% of its 52-week range. The latest completed week returned 4.7%, after a -15.1% four-week move. The latest news-sentiment score is 45/100.
Setup score
57
out of 100
Latest Close
1,010 MXN
7 Aug 2026
1W Return
4.7%
latest completed week
4W Return
-15.1%
short-term follow-through
12W Return
20.8%
quarterly tape
Trend Breadth
57.7%
30 of 52 weeks active
Volume Ratio
2.3x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
4.7%
Latest completed week; four-week move -15.1%.
Indicator stack
77/45
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
45/100
17 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 9.7% above the Trend Line and sits at 57.5% of its 52-week range. The latest completed week returned 4.7%, after a -15.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 2.3x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5812-week average 0.54
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.58Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -15.1% over four weeks, 20.8% over 12 weeks, and 107.8% over one year. The current trend has remained active for 30 consecutive weeks.
Performance by holding period
Active trend streak30 weeks
Active weeks in one year30
Trend breadth57.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.09Latest activity-pressure read.
Pressure change-88.2%Four-week change in activity pressure.
Leadership34.68Latest relative-leadership reading.
RS change-47.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment45/100
Weighted news tone is neutral across 17 relevant articles.
1 positive · 14 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-30.4%Distance below the 52-week high.
13-week volatility12.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher15 of 2611 weeks finished lower.
Best week+30.7%Week of 19 Jun.
Worst week-14.1%Week of 10 Jul.
Latest week+4.7%Week of 7 Aug.
Shape of recent returns
Strong gains9
Modest gains6
Flat weeks0
Modest losses5
Sharp losses6
Recent vol12.1%13-week weekly-return volatility.
Base vol9.5%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew8.4% / -6.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorMX Healthcare
4-week rank71 / 78
Group average-1.2%
Trend breadth29.5%
Trend29.5%active weekly trend signals
MD62.8%positive activity pressure
RS35.9%positive relative leadership
Four-week leaders
IndustryMX Biotechnology
4-week rank14 / 19
Group average-8.7%
Trend breadth15.8%
Trend15.8%active weekly trend signals
MD36.8%positive activity pressure
RS21.1%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape61/100
Trend, activity pressure, participation, and risk combine to a 61/100 tape read.
Indicator analysis73/100Latest 12-week confirmation: trend 12/12, activity pressure 6/12, relative leadership 12/12.
Activity pressure 0.58; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment45/100Weighted news tone is neutral across 17 relevant articles.
Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage? Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1,010 MXN | 4.7% | 920.5 MXN | 1,121 MXN | 0.09 | 34.68 | 4.3K | On |
| 31 Jul 2026 | 965.0 MXN | 1.9% | 907.4 MXN | 1,126 MXN | 0.30 | 30.18 | 1.2K | On |
| 24 Jul 2026 | 947.0 MXN | -13.9% | 893.7 MXN | 1,132 MXN | 0.61 | 30.03 | 735 | On |
| 17 Jul 2026 | 1,100 MXN | -7.5% | 880.8 MXN | 1,139 MXN | 0.82 | 51.32 | 2.6K | On |
| 10 Jul 2026 | 1,190 MXN | -14.1% | 864.5 MXN | 1,145 MXN | 0.79 | 65.77 | 8.6K | On |
| 3 Jul 2026 | 1,384 MXN | 19.0% | 842.5 MXN | 1,151 MXN | 0.35 | 93.63 | 0 | On |
| 26 Jun 2026 | 1,164 MXN | 4.2% | 813.1 MXN | 1,155 MXN | -0.16 | 65.65 | 2.1K | On |
| 19 Jun 2026 | 1,117 MXN | 30.7% | 790.0 MXN | 1,161 MXN | -0.55 | 60.41 | 0 | On |
| 12 Jun 2026 | 855.0 MXN | 3.2% | 767.2 MXN | 1,167 MXN | -0.83 | 24.08 | 97 | On |
| 5 Jun 2026 | 828.8 MXN | -1.8% | 753.9 MXN | 1,176 MXN | -0.77 | 24.49 | 216 | On |
| 29 May 2026 | 844.0 MXN | 2.9% | 741.3 MXN | 1,184 MXN | -0.57 | 23.09 | 1.3K | On |
| 22 May 2026 | 820.2 MXN | -1.9% | 730.1 MXN | 1,193 MXN | -0.55 | 20.85 | 979 | On |
| 15 May 2026 | 836.0 MXN | -10.0% | 719.0 MXN | 1,202 MXN | -0.35 | 24.65 | 1.8K | On |
| 8 May 2026 | 929.4 MXN | 16.2% | 707.0 MXN | 1,211 MXN | -0.03 | 35.90 | 5.5K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.